PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Dichloromethane extract and its fractions diminished joint inflammation and pain in a kaolin/carrageenan induced mono-arthritis mice model [PMID:32342135].
Extracts and fractions demonstrated acute and chronic antihypertensive activity in mice and counteracted kidney inflammation [PMID:30606987].
Leaf extract and nano-formulations showed antidiabetic activity in streptozotocin-induced diabetic rats [PMID:36531617].
Ethanolic extracts were tested for wound healing properties in an in vivo rat wound excision model [PMID:39490430].
Hydroalcoholic leaf extract ameliorated cognitive deficits and reduced inflammatory response in 5XFAD transgenic mice [PMID:31291963, 31545221].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 40506390 (2025) — Suspected marsh mallow (Malva parviflora) toxicosis in ponies-Case cluster including an asymptomatic survivor. · Australian veterinary journal
- 2.PMID: 39116155 (2024) — Anti-adipogenic effect of Malva parviflora on 3T3-L1 adipocytes. · PloS one
- 3.PMID: 33935565 (2021) — Biosynthesis of silver nanoparticles using Malva parviflora and their antifungal activity. · Saudi journal of biological sciences
- 4.PMID: 27341541 (2017) — Evidence for marsh mallow (Malva parviflora) toxicosis causing myocardial disease and myopathy in four horses. · Equine veterinary journal
- 5.PMID: 19576789 (2009) — Leaf photosynthetic and solar-tracking responses of mallow, Malva parviflora, to photon flux density.